1. Home
  2. TOI vs EVMN Comparison

TOI vs EVMN Comparison

Compare TOI & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$5.08

Market Cap

497.9M

Sector

Health Care

ML Signal

HOLD

Logo Evommune Inc.

EVMN

Evommune Inc.

HOLD

Current Price

$11.41

Market Cap

405.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOI
EVMN
Founded
2007
2020
Country
United States
United States
Employees
641
48
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
497.9M
405.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TOI
EVMN
Price
$5.08
$11.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$6.67
$43.88
AVG Volume (30 Days)
1.9M
689.9K
Earning Date
05-07-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.15
N/A
Revenue Next Year
$25.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$10.47
52 Week High
$6.67
$33.20

Technical Indicators

Market Signals
Indicator
TOI
EVMN
Relative Strength Index (RSI) 47.78 34.28
Support Level $4.90 $10.47
Resistance Level $5.63 $21.21
Average True Range (ATR) 0.37 0.81
MACD -0.08 0.29
Stochastic Oscillator 24.22 38.68

Price Performance

Historical Comparison
TOI
EVMN

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: